Quaker Chemical Corporation
Income Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.89B | $1.84B | $1.95B | $1.94B | $1.76B | $1.42B | $1.13B | $867.5M |
| Cost of Revenue | $1.21B | $1.15B | $1.25B | $1.33B | $1.17B | $904.2M | $741.4M | $555.2M |
| Gross Profit | $679.4M | $686.0M | $705.6M | $612.7M | $594.6M | $513.4M | $392.1M | $312.3M |
| Gross Margin | 36.0% | 37.3% | 36.1% | 31.5% | 33.8% | 36.2% | 34.6% | 36.0% |
| Operating Expenses | ||||||||
| Research & Development | $60.7M | $57.3M | $50.3M | $46.0M | $44.9M | $40.0M | $32.1M | $24.5M |
| SG&A Expense | $502.4M | $484.8M | $483.6M | $464.2M | $418.9M | $380.8M | $283.8M | $207.9M |
| Operating Income | $53.0M | $194.7M | $214.5M | $52.3M | $150.5M | $59.4M | $46.1M | $87.8M |
| Operating Margin | 2.8% | 10.6% | 11.0% | 2.7% | 8.5% | 4.2% | 4.1% | 10.1% |
| Interest Expense | $42.6M | $43.2M | $50.7M | $32.6M | $22.3M | $26.6M | $17.0M | $4.0M |
| Pretax Income | $7.0M | $155.1M | $153.1M | $7.1M | $147.0M | $27.1M | $28.9M | $83.1M |
| Income Tax Expense | $24.6M | $49.3M | $55.6M | $24.9M | $34.9M | $-5.3M | $2.1M | $25.1M |
| Net Income | $-2.5M | $116.6M | $112.7M | $-15.9M | $121.4M | $39.7M | $31.6M | $59.5M |
| Net Margin | -0.1% | 6.3% | 5.8% | -0.8% | 6.9% | 2.8% | 2.8% | 6.9% |
| EPS (Basic) | $-0.14 | $6.51 | $6.27 | $-0.89 | $6.79 | $2.23 | $2.08 | $4.46 |
| EPS (Diluted) | $-0.14 | $6.51 | $6.26 | $-0.89 | $6.77 | $2.22 | $2.08 | $4.45 |
| Shares Outstanding (Basic) | 17.5M | 17.9M | 17.9M | 17.8M | 17.8M | 17.7M | 15.1M | 13.3M |
| Shares Outstanding (Diluted) | 17.5M | 17.9M | 17.9M | 17.9M | 17.9M | 17.8M | 15.2M | 13.3M |
| Dividends Per Share | $1.99 | $1.88 | $1.78 | $1.70 | $1.62 | $1.56 | $1.53 | $1.47 |